Designer probiotics may able to suppress astrocyte-mediated CNS inflammation that drives the progressive phase of MS, according to a keynote speaker at PACTRIMS 2018 in Sydney. Dr Francisco Javier Quintana, of the Department of Neurology, Brigham and Women’s Hospital in Boston, opened the conference by saying that his group’s focus was on elucidating the pathways ...
Microbiota, astrocytes may be key pathways in MS inflammation
By Michael Woodhead
2 Nov 2018